Rico Buchli

Dr. Buchli earned his Ph.D. in Biochemistry from the University of Basel in 1996. He served as Postdoctoral Researcher at UC Davis under Drs. Sergei Grando and Dick Robbins before accepting a Research Assistant Professor position at the University of Oklahoma Health Science Center. He joined Pure Protein, LLC in 2001 as the Director of Research.

Dr. Buchli has over 15 years of experience in molecular biology, biochemistry and immunology, including expertise in protein purification, characterization and detection through the use of antigen-specific antibodies. He has also previously served as a consultant to several clinical transplantation HLA platform providers such as Dynal Biotech and Lifecodes. He has authored 50+ publications, served on several journal review boards, and mentored students from the Oklahoma School of Science and Mathematics. Appointed by the Swiss Ministry of Foreign Affairs, Dr. Buchli serves as an Honorary Consul of Switzerland, and he is an appointed member of the Oklahoma Governor’s International Team (GIT). He is also the recipient of the Albert M. Kligman Award in Dermatology and The Journal Record’s “On the Brink Innovator Award.” Dr Buchli is a co-inventor on multiple International and U.S. patents.

Using Pure Protein’s patented sHLA core technology for large-scale production of secreted sHLA proteins, Dr. Buchli has designed unique methods for sHLA stabilization and application in multiple assay systems including peptide binding assays utilized by customers such as the FDA and other research entities, both public and private. He also leads development of products for use in clinical transplant screening and other HLA-research related applications to include ELISA, Luminex-bead and Chip-microarray platforms.